Summary
The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award where the first phase can be used to finalize required pre-trial activities such as stability, shipping studies, and site training.
Eligibility
- Independent School Districts
- Small Businesses
- For Profit Organizations Other Than Small Businesses
- Special District Governments
- Nonprofits Non Higher Education Without 501c3
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- City Or Township Governments
- Native American Tribal Governments Federally Recognized
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- Public and State Institutions of Higher Education
- Public and Indian Housing Authorities
- State Governments
- Private Institutions of Higher Education
- County Governments
- Other
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record